Zacks upgrades Nu Skin stock from strong sell to hold

Published on 10/20/2026 at 18:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue was USD 320.11 million versus USD 345.20 million. Nu Skin stock costs USD 5.01 on October 20, 2026, up 0.80 percent on NYSE.

Analyst rating and financial strain

Zacks Research upgraded Nu Skin from strong sell to hold on October 14, 2026.
Second-quarter revenue was USD 320.11 million against USD 345.20 million consensus.
Nu Skin stock cost USD 5.01 on October 20, 2026, up 0.80 percent on the NYSE.
Market capitalization was USD 244.1 million on October 20, 2026.

NUS, US67018T1051, Illustration mit AI erstellt.

Zacks Research upgraded Nu Skin from strong sell to hold in a report dated October 14, 2026, according to MarketBeat. Nu Skin stock was at USD 5.01 on October 20, 2026 at 12:55 p.m. ET, up 0.80 percent from the prior NYSE close of USD 4.97.

Revenue remains below estimates

The latest reported quarter ended June 30, 2026. Revenue was USD 320.11 million, below the USD 345.20 million analyst estimate cited by MarketBeat. That gap of USD 25.09 million was 7.27 percent of the estimate, keeping revenue execution central to the investment case.

Nu Skin's investor-relations page identifies the company as listed on the New York Stock Exchange and links its second-quarter 2026 results, released on August 10, 2026, Nu Skin states. The company sells beauty, wellness and personal-care products through direct-selling and digital channels.

Stock stays near its yearly low

The NYSE quote stood 12.58 percent above Nu Skin's 52-week low of USD 4.45 and 57.07 percent below its 52-week high of USD 11.67 on October 20, 2026. Trading volume was 101,791 shares, compared with an average volume of 536,478 shares.

The share price was 4.88 percent above its 50-day moving average of USD 4.78 and 10.85 percent below its 200-day moving average of USD 5.62, figures reported by MarketBeat.

Valuation and peer comparison

Nu Skin had a market capitalization of USD 244.1 million and a negative price-to-earnings ratio of -1.12 on October 20, 2026. The company also carried full-year 2026 adjusted earnings-per-share guidance of USD 0.70 to USD 0.90, while third-quarter guidance was USD 0.10 to USD 0.20, according to MarketBeat.

Comparison with peers

Nu Skin: up 0.80 percent, price-to-earnings ratio -1.12, market capitalization USD 244.1 million.

Inter Parfums (NYSE, USD): up 1.47 percent, price-to-earnings ratio 22.29, market capitalization USD 3.7 billion.

e.l.f. Beauty (NYSE, USD): up 1.08 percent, price-to-earnings ratio 114.68, market capitalization USD 6.8 billion.

Nu Skin remains financially pressured

The October 14 rating change offers a more constructive view than the company's recent revenue performance, but the valuation remains shaped by the USD 25.09 million second-quarter revenue shortfall. The next financial milestone is the release of third-quarter results, for which analysts estimate revenue of USD 350.33 million, according to Business Quant.

Nu Skin stock was valued at USD 244.1 million on October 20, 2026, while its USD 4.45 52-week low remained the closest major price marker.